K-V Pharmaceutical Company Announces $200 Million Private Debt Offering PR Newswire ST. LOUIS, March 1, 2011 ST. LOUIS, March 1, 2011...
KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call Comments PR Newswire ST. LOUIS, Feb. 14...
K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue Warrants in...
K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock COMPANY ANNOUNCES AGREEMENT OF TERMS...
K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011 PR Newswire ST. LOUIS, Feb. 4, 2011 ST. LOUIS, Feb. 4, 2011...
K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™ PR Newswire ST. LOUIS, Jan. 12, 2011 ST. LOUIS, Jan. 12, 2011...
K-V Pharmaceutical Co. (KVA, KVB) has reached a $20 million loan agreement in the wake of a recent U.S. Food and Drug Administration approval as...
K-V Pharmaceutical Co. (KVA, KVB) has received permission from the U.S. Food and Drug Administration to return its first product to market...
ST. LOUIS, Feb. 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) ("the Company") today announced that it has reached an...
Robbins Umeda LLP has commenced an investigation into possible mismanagement of KV Pharmaceutical Company ("KV" or the "Company...
Watson Pharmaceuticals Inc. (WPI) has grabbed a large share of the market for a generic version of AstraZeneca PLC's (AZN, AZN.LN) blood pressure...
Watson Pharmaceuticals Inc. (WPI) has grabbed a large share of the market for a generic version of AstraZeneca Plc's (AZN AZN.LN) blood pressure...
ST. LOUIS, Jan. 11 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) today announced it has entered into an amendment to the...
ST. LOUIS, Jan. 7 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) today announced that IVS Associates, Inc., the inspector of...
ST. LOUIS, Dec. 22 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) (the "Company") received permission from the New York...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.